Connection

Floriane Gallais to Humans

This is a "connection" page, showing publications Floriane Gallais has written about Humans.
Connection Strength

0.053
  1. Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection. EBioMedicine. 2021 Sep; 71:103561.
    View in: PubMed
    Score: 0.008
  2. Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France. Emerg Infect Dis. 2021 01; 27(1).
    View in: PubMed
    Score: 0.007
  3. Multilocus sequence typing of clinical Borreliella afzelii strains: population structure and differential ability to disseminate in humans. Parasit Vectors. 2018 Jun 28; 11(1):374.
    View in: PubMed
    Score: 0.006
  4. Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature. BMC Infect Dis. 2017 08 02; 17(1):535.
    View in: PubMed
    Score: 0.006
  5. [Field assessment of the new rapid diagnostic test Ebola eZYSCREEN®]. Bull Soc Pathol Exot. 2017 Feb; 110(1):38-48.
    View in: PubMed
    Score: 0.006
  6. Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2021 09 17; 224(6):983-988.
    View in: PubMed
    Score: 0.002
  7. Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19. Am J Transplant. 2021 11; 21(11):3808-3810.
    View in: PubMed
    Score: 0.002
  8. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021 08; 596(7871):276-280.
    View in: PubMed
    Score: 0.002
  9. Outbreak of SARS-CoV-2 infection in a long-term care facility after COVID-19 BNT162b2 mRNA vaccination. Clin Microbiol Infect. 2021 10; 27(10):1537-1539.
    View in: PubMed
    Score: 0.002
  10. Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020. Euro Surveill. 2020 12; 25(48).
    View in: PubMed
    Score: 0.002
  11. The social and clinical impact of the COVID-19 epidemic on the Strasbourg lung transplant cohort: A single-center retrospective cohort study. Clin Transplant. 2020 12; 34(12):e14119.
    View in: PubMed
    Score: 0.002
  12. In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020 11; 20(11):3162-3172.
    View in: PubMed
    Score: 0.002
  13. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies. Diagn Microbiol Infect Dis. 2020 Dec; 98(4):115181.
    View in: PubMed
    Score: 0.002
  14. Bilateral Acute Cardioembolic Limb Ischemia After Coronavirus Disease 2019 Pneumonia in a Lung Transplant Recipient: A Case Report. Transplant Proc. 2020 Nov; 52(9):2715-2718.
    View in: PubMed
    Score: 0.002
  15. Delayed pulmonary abscess following COVID-19 pneumonia: A case report. Respir Med Res. 2020 11; 78:100776.
    View in: PubMed
    Score: 0.002
  16. Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens. Paediatr Drugs. 2018 Aug; 20(4):375-381.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.